Publication | Open Access

Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma

Surgical OncologyPancreatic CancerMedicinePharmacologyPathologyLong-term Clinical OutcomeSomatostatin AnaloguesOncologyRadiation OncologyEndocrine-related Cancer